Project gets green light for construction to commence.
Investment decision still under discussion.
Development of a biogas plant using chemical factory waste.
On 23rd March 2017, Novozymes, Novo Nordisk, DONG Energy (now known as Ørsted) and Bigadan announced that they are to proceed with the construction of a large-scale biogas plant that will reuse residues from the production facilities of Novozymes and Novo Nordisk in Kalundborg on Zealand. The companies have revealed that they were investigating the possibility of establishing the plant back in September 2015.
Novo Nordisk and Novozymes have extensive factory facilities in Kalundborg on Zealand which produce enzymes and insulin. Biomass is a by-product from production, already used as a fertiliser and also utilised by Novo Nordisk to produce biogas at installations around Zealand.
Bigadan and DONG Energy will build and own the biogas plant which will be located close to DONG Energy's power station in Kalundborg. Bigadan will operate the plant, and Novo Nordisk and Novozymes will supply biomass from their factories in Kalundborg and Novozymes' factory at Fuglebakken in Copenhagen.
The biogas plant will have a production capacity of 8 million cubic metres of natural gas per year. This corresponds to the natural gas consumption of approximately 5,000 households and represents more than half of the households in Kalundborg. Biomass residues will continue to be used as fertiliser in Zealand's agricultural sector.
Ørsted advised AcuComm that construction of the new biogas plant commenced on 29th May 2017, two months later than originally planned. Commissioning was expected in spring 2018.
In April 2018, Ørsted updated AcuComm, confirming that the commissioning will be in
multiple steps and that it is currently in the early stage of commissioning. The facility is expected to be fully
operational during late spring/early summer with the official inauguration planned
for June 2018.